Impulse (Qingdao) Health Tech Co.,Ltd. (SHE:002899)
31.73
-0.26 (-0.81%)
At close: Feb 6, 2026
SHE:002899 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,170 | 1,210 | 893.5 | 822.39 | 862.15 | 865.29 |
Other Revenue | 3.57 | 3.57 | 1.82 | 2.31 | 2.24 | 2.69 |
| 1,173 | 1,214 | 895.32 | 824.7 | 864.39 | 867.98 | |
Revenue Growth (YoY) | 3.55% | 35.58% | 8.56% | -4.59% | -0.41% | -7.43% |
Cost of Revenue | 855.26 | 839.04 | 620.5 | 623.01 | 649.95 | 585.77 |
Gross Profit | 318.02 | 374.81 | 274.82 | 201.68 | 214.45 | 282.22 |
Selling, General & Admin | 163.04 | 165.09 | 134.78 | 114.24 | 116.87 | 151.08 |
Research & Development | 54.68 | 52.55 | 41.09 | 39.89 | 46.61 | 69.33 |
Other Operating Expenses | 19.48 | 11.19 | 2.9 | -0.71 | 4.89 | 9.13 |
Operating Expenses | 255.62 | 249.41 | 191.28 | 170.88 | 179.26 | 240.33 |
Operating Income | 62.4 | 125.4 | 83.54 | 30.8 | 35.18 | 41.89 |
Interest Expense | -20.21 | -23.22 | -0.45 | -0.26 | -0.29 | -0.01 |
Interest & Investment Income | 13.93 | 14.2 | 12.81 | 4.55 | 6.73 | 7.78 |
Currency Exchange Gain (Loss) | 10.21 | 10.21 | 4.17 | 13.32 | -3.99 | -14.25 |
Other Non Operating Income (Expenses) | -1.22 | -0.56 | -0.43 | -0.71 | -2.16 | 0.02 |
EBT Excluding Unusual Items | 65.1 | 126.03 | 99.65 | 47.7 | 35.48 | 35.43 |
Gain (Loss) on Sale of Investments | -0.21 | -1.01 | 1.38 | 0.5 | - | 0.13 |
Gain (Loss) on Sale of Assets | -0.12 | -0.15 | -0.08 | 0.38 | -0.02 | -0.02 |
Asset Writedown | 16.94 | -2.92 | -0.44 | -2.91 | -0.01 | -0.85 |
Other Unusual Items | 1.74 | 0.16 | 0.7 | -0.25 | -17.96 | 6.03 |
Pretax Income | 83.45 | 122.12 | 101.2 | 45.43 | 17.49 | 40.71 |
Income Tax Expense | 10.9 | 13 | 13.04 | -20.24 | 0.06 | 1.15 |
Net Income | 72.56 | 109.12 | 88.16 | 65.66 | 17.43 | 39.56 |
Net Income to Common | 72.56 | 109.12 | 88.16 | 65.66 | 17.43 | 39.56 |
Net Income Growth | -29.44% | 23.77% | 34.26% | 276.69% | -55.94% | -21.75% |
Shares Outstanding (Basic) | 146 | 138 | 121 | 119 | 116 | 120 |
Shares Outstanding (Diluted) | 146 | 138 | 121 | 119 | 116 | 120 |
Shares Change (YoY) | 10.54% | 14.37% | 1.16% | 2.73% | -3.06% | -0.41% |
EPS (Basic) | 0.50 | 0.79 | 0.73 | 0.55 | 0.15 | 0.33 |
EPS (Diluted) | 0.50 | 0.79 | 0.73 | 0.55 | 0.15 | 0.33 |
EPS Growth | -36.17% | 8.22% | 32.73% | 266.67% | -54.55% | -21.43% |
Free Cash Flow | 158.71 | 32.57 | -47.75 | -350.57 | -370.16 | 73.16 |
Free Cash Flow Per Share | 1.09 | 0.24 | -0.40 | -2.94 | -3.19 | 0.61 |
Dividend Per Share | 0.075 | 0.075 | 0.071 | 0.063 | 0.022 | 0.039 |
Dividend Growth | 5.63% | 5.63% | 12.70% | 186.36% | -43.59% | - |
Gross Margin | 27.11% | 30.88% | 30.70% | 24.45% | 24.81% | 32.51% |
Operating Margin | 5.32% | 10.33% | 9.33% | 3.74% | 4.07% | 4.83% |
Profit Margin | 6.18% | 8.99% | 9.85% | 7.96% | 2.02% | 4.56% |
Free Cash Flow Margin | 13.53% | 2.68% | -5.33% | -42.51% | -42.82% | 8.43% |
EBITDA | 140.87 | 178.22 | 102.14 | 52.77 | 58.19 | 62.09 |
EBITDA Margin | 12.01% | 14.68% | 11.41% | 6.40% | 6.73% | 7.15% |
D&A For EBITDA | 78.48 | 52.81 | 18.6 | 21.97 | 23.01 | 20.2 |
EBIT | 62.4 | 125.4 | 83.54 | 30.8 | 35.18 | 41.89 |
EBIT Margin | 5.32% | 10.33% | 9.33% | 3.74% | 4.07% | 4.83% |
Effective Tax Rate | 13.06% | 10.65% | 12.88% | - | 0.34% | 2.83% |
Revenue as Reported | 1,173 | 1,214 | 895.32 | 824.7 | 864.39 | 867.98 |
Advertising Expenses | - | 11.27 | 9.49 | 7.6 | 11.02 | 9.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.